HCW Biologics says B&I Contractors drops Florida lien crossclaims, settles dispute over USD 1.1 million lien
HCW Biologics, Inc. HCWB | 0.00 |
- HCW Biologics disclosed a settlement that ends litigation tied to a mechanics’ lien on its Miramar, Florida renovation site.
- B&I Contractors filed a voluntary dismissal with prejudice of its crossclaims in BE&K Building Group v. HCW Biologics, dated June 26, 2026.
- B&I also filed a final satisfaction of lien, removing a USD 1.1 million lien and fully resolving amounts owed under the settlement.
- The company expects to report settlement-related extinguishment of USD 2.8 million of disputed accounts payable for the quarter ended June 30, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCW Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031441), on July 01, 2026, and is solely responsible for the information contained therein.
